Voyager Therapeutics (VYGR) Cash from Operations Growth (3y) (2017 - 2026)
Voyager Therapeutics (VYGR) Cash from Operations Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | - |
| 10 | Voyager Therapeutics | 193.96 Mn | 52.48 Mn | - | -31.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.43% |
| Dec 31, 2025 | -35.21% |
| Sep 30, 2025 | -24.20% |
| Jun 30, 2025 | -21.63% |
| Mar 31, 2025 | -45.82% |
| Dec 31, 2024 | -48.85% |
| Sep 30, 2024 | -10.54% |
| Jun 30, 2024 | -11.61% |
| Mar 31, 2024 | 68.21% |
| Dec 31, 2023 | -2.63% |
| Sep 30, 2023 | 5.24% |
| Jun 30, 2023 | 65.98% |
| Mar 31, 2023 | 84.60% |
| Dec 31, 2022 | 19.37% |
| Sep 30, 2022 | 9.10% |
| Jun 30, 2022 | 16.33% |
| Mar 31, 2022 | -34.97% |
| Dec 31, 2021 | 34.99% |
| Sep 30, 2021 | -5.48% |
| Jun 30, 2021 | -0.32% |